Exercise does not enhance the prognostic value of Doppler echocardiography in patients with left ventricular systolic dysfunction and functional mitral regurgitation at rest

American Heart Journal

Volumn 155, Issue 4, 2008, Pages 752-757

  Ennezat, Pierre V ^a   Maréchaux, Sylvestre ^a   Huerre, Clémence ^a   Deklunder, Ghislaine ^a,b   Asseman, Philippe ^a,b   Jude, Brigitte ^b   Van Belle, Eric ^a,b   Mouquet, Frédéric ^a,b   Bauters, Christophe ^a,b   Lamblin, Nicolas ^a   LeJemtel, Thierry H ^c   de Groote, Pascal ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DOPPLER ECHOCARDIOGRAPHY; EXERCISE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SYSTOLIC BLOOD PRESSURE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 40949144449     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.11.022     Document Type: Article

References (27)

1. Mancini D.M., Eisen H., Kussmaul W., et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83 (1991) 778-786
2. de Groote P., Dagorn J., Soudan B., et al. B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. J Am Coll Cardiol 43 (2004) 1584-1589
3. Cohn J.N., Johnson G.R., Shabetai R., et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 87 6 Suppl (1993) V15-V16
4. Faris R., Coats A., and Henein M. Echocardiography-derived variables predict outcome in patients with nonischemic dilated cardiomyopathy with or without a restrictive filling pattern. Am Heart J 144 (2002) 343-350
5. Dini F., Conti U., Fontanive P., et al. Right ventricular dysfunction is a major predictor of outcome in patients with moderate to severe mitral regurgitation and left ventricular dysfunction. Am Heart J 154 (2007) 172-179
6. Ghio S., Recusani F., Klersy C., et al. Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol 85 (2000) 837-842
7. Robbins J.D., Maniar P.B., Cotts W., et al. Prevalence and severity of mitral regurgitation in chronic systolic heart failure. Am J Cardiol 91 (2003) 360-362
8. Ennezat P.V., Marechaux S., Asseman P., et al. Functional mitral regurgitation and chronic heart failure. Minerva Cardioangiol 54 (2006) 725-733
9. Stevenson L.W., Bellil D., Grover-McKay M., et al. Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 60 (1987) 654-658
10. Keren G., Laniado S., Sonnenblick E.H., et al. Dynamics of functional mitral regurgitation during dobutamine therapy in patients with severe congestive heart failure: a Doppler echocardiographic study. Am Heart J 118 (1989) 748-754
11. Keren G., Katz S., Strom J., et al. Dynamic mitral regurgitation. An important determinant of the hemodynamic response to load alterations and inotropic therapy in severe heart failure. Circulation 80 (1989) 306-313
12. Lancellotti P., Troisfontaines P., Toussaint A., et al. Prognostic importance of exercise-induced changes in mitral regurgitation in patients with chronic ischemic left ventricular dysfunction. Circulation 108 (2003) 1713-1717
13. Lebrun F., Lancellotti P., and Pierard L.A. Quantitation of functional mitral regurgitation during bicycle exercise in patients with heart failure. J Am Coll Cardiol 38 (2001) 1685-1692
14. Ennezat P.V., Gal B., Kouakam C., et al. Cardiac resynchronisation therapy reduces functional mitral regurgitation during dynamic exercise in patients with chronic heart failure: an acute echocardiographic study. Heart 92 (2006) 1091-1095
15. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112 (2005) e154-e235
16. Senni M., Rodeheffer R.J., Tribouilloy C.M., et al. Use of echocardiography in the management of congestive heart failure in the community. J Am Coll Cardiol 33 (1999) 164-170
17. St John Sutton M., Pfeffer M.A., Plappert T., et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation 89 (1994) 68-75
18. Giannuzzi P., Temporelli P.L., Bosimini E., et al. Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction. J Am Coll Cardiol 28 (1996) 383-390
19. Blondheim D.S., Jacobs L.E., Kotler M.N., et al. Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus. Am Heart J 122 (1991) 763-771
20. Seneviratne B., Moore G.A., and West P.D. Effect of captopril on functional mitral regurgitation in dilated heart failure: a randomised double blind placebo controlled trial. Br Heart J 72 (1994) 63-68
21. Capomolla S., Febo O., Gnemmi M., et al. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Am Heart J 139 (2000) 596-608
22. Breithardt O.A., Sinha A.M., Schwammenthal E., et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 41 (2003) 765-770
23. Kanzaki H., Bazaz R., Schwartzman D., et al. A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy: insights from mechanical activation strain mapping. J Am Coll Cardiol 44 (2004) 1619-1625
24. Lancellotti P., Melon P., Sakalihasan N., et al. Effect of cardiac resynchronization therapy on functional mitral regurgitation in heart failure. Am J Cardiol 94 (2004) 1462-1465
25. Cleland J.G., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
26. de Groote P., Millaire A., Foucher-Hossein C., et al. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol 32 (1998) 948-954
27. Kaul S., Tei C., Hopkins J.M., and Shah P.M. Assessment of right ventricular function using two-dimensional echocardiography. Am Heart J 107 (1984) 526-531